Uncategorized

Edwards, which has made a series of acquisitions in recent months, is also investing $25 million in Singapore-based Genesis Medtech.

The acquisition of the medical device contract manufacturer comes as DuPont prioritizes expansion in the healthcare sector.

Inflation, expensive specialty drugs and demand for pricey glucagon-like peptide 1 medications, or GLP-1s, are pushing costs higher, according to the professional services company.

The case centered on whether patients who receive funds from a pool of state funding for uncompensated care could be included in calculating hospitals’ disproportionate share funding.

SIGA Technologies’ TPOXX did not outperform placebo at resolving lesions in patients with clade I mpox, the new strain that has spread through parts of Africa and is reaching beyond the continent.

The unit’s closure comes as Genentech’s parent Roche rethinks its cancer business, an effort that has included the discontinuation of three early-stage candidates and a T-cell partnership with Adaptimmune.

The FDA on Monday only granted Liquidia’s Yutrepia tentative approval, keeping it off the U.S. market until after rival United Therapeutics’ exclusivity expires in May 2025.

The Danish company on Saturday announced plans to increase production of its vaccine Jynneos on the heels of the World Health Organization last week declaring mpox a global health emergency.

The decline doesn’t mean the sector’s financial challenges have gone away, and case volumes could increase later this year, according to healthcare restructuring advisory firm Gibbins Advisors.

By building and nurturing a strong personal brand, you can benefit in multiple ways, including enhancing your credibility, attracting opportunities and inspiring investor confidence.